OR WAIT 15 SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
February 02, 2021
Outsourcing partners can provide a multitude of advantages in the development of drug delivery solutions, including those designed for targeted patient populations.
Open communication and transparency coupled with technical expertise foster strong long-term manufacturing partnerships.
From scale-up and tech transfer to analytical method development and quality testing, alliances between innovators and contract partners, and between CDMOs and technology vendors, are taking more therapies from lab to patient.
Collaboration between equipment suppliers and users is leading to innovation and optimization in biopharmaceutical manufacturing.
For drug sponsors that are considering building their own manufacturing facilities, an expert project team is crucial.
CDMOs address the unique challenges of liquid and lyophilized forms as well as preparing for the large capacity needed for COVID-19 vaccines.
With appropriate planning and the proper use of technology, remote auditing can be as effective and informative as in-person auditing.
February 01, 2021
Best practices can help ensure supply chain flexibility and viability for biologic drugs in clinical trials.
Contract development and manufacturing organizations provide vital services to rush COVID-19 vaccines to patients.